The present invention is drawn to novel antiviral compounds, pharmaceutical compositions
and their use. More specifically this invention is drawn to derivatives of monocyclic
polyamines which have activity in standard tests against HIV- or FIV-infected cells
as well as other biological activity related to binding of ligands to chemokine
receptors that mediate a number of mammalian embryonic developmental processes.